Mitochondrial DNA damage is a hallmark of chemically-induced and the r6/2 Transgenic models of Huntington's disease

被引：0
|
作者：
Acevedo-Torres, K. [1 ]
Berrios, L. [2 ]
Rosario, N. [2 ]
Dufault, V [1 ]
Skatchkov, S. [2 ]
Eaton, M. J. [2 ]
Torres-Ramos, C. A. [1 ]
Ayala-Torres, S. [1 ]
机构：
[1] Univ Puerto Rico, San Juan, PR 00936 USA
[2] Univ Cent Caribe, San Juan, PR USA
来源：
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS | 2008年 / 49卷 / 07期
关键词：
D O I：
暂无
中图分类号：
X [环境科学、安全科学];
学科分类号：
08 ; 0830 ;
摘要：
引用
收藏
页码：522 / 522
页数：1
相关论文
共 50 条
  • [21] CAG repeat lengths ≥335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse
    Dragatsis, I.
    Goldowitz, D.
    Del Mar, N.
    Deng, Y. P.
    Meade, C. A.
    Liu, Li
    Sun, Z.
    Dietrich, P.
    Yue, J.
    Reiner, A.
    NEUROBIOLOGY OF DISEASE, 2009, 33 (03) : 315 - 330
  • [22] The R6 lines of transgenic mice: A model for screening new therapies for Huntington's disease
    Gil, Joana M.
    Rego, A. Cristina
    BRAIN RESEARCH REVIEWS, 2009, 59 (02) : 410 - 431
  • [23] Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice
    Klapstein, GJ
    Fisher, RS
    Zanjani, H
    Cepeda, C
    Jokel, ES
    Chesselet, MF
    Levine, MS
    JOURNAL OF NEUROPHYSIOLOGY, 2001, 86 (06) : 2667 - 2677
  • [24] Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease
    S Zhu
    Y Zhang
    G Bai
    H Li
    Cell Death & Disease, 2011, 2 : e115 - e115
  • [25] A Comprehensive Description of the Progressive Pathology Exhibited by the R6/2 Transgenic Mouse Model of Huntington's Disease
    Rattray, I.
    Gale, R.
    Smith, E.
    Matsumoto, K.
    Bates, G.
    Modo, M.
    CELL TRANSPLANTATION, 2012, 21 (04) : 788 - 788
  • [26] Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice
    Bolivar, VJ
    Manley, K
    Messer, A
    BRAIN RESEARCH, 2004, 1005 (1-2) : 29 - 35
  • [27] Impaired glucose tolerance in the R6/1 transgenic mouse model of Huntington's disease
    Josefsen, K.
    Nielsen, M. D.
    Jorgensen, K. H.
    Bock, T.
    Norremolle, A.
    Sorensen, S. A.
    Naver, B.
    Hasholt, L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2008, 20 (02) : 165 - 172
  • [28] Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease
    Zhu, S.
    Zhang, Y.
    Bai, G.
    Li, H.
    CELL DEATH & DISEASE, 2011, 2 : e115 - e115
  • [29] Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6/1 and R6/2 mouse models of Huntington's disease
    van der Borght, Karin
    Brundin, Patrik
    EXPERIMENTAL NEUROLOGY, 2007, 204 (01) : 473 - 478
  • [30] Chronology of Behavioral Symptoms and Neuropathologic Sequellae in R6/2 Huntington Disease Transgenic Mice
    Newsome, J. T.
    Ferrante, R. J.
    Fellows-Mayle, W.
    Friedlander, R. M.
    JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE, 2011, 50 (05): : 740 - 740
12345